IHZ Trademark

Trademark Overview


On Thursday, August 27, 2015, a trademark application was filed for IHZ with the United States Patent and Trademark Office. The USPTO has given the IHZ trademark a serial number of 86739853. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 24, 2019. This trademark is owned by CytomX Therapeutics, Inc.. The IHZ trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Assays and reagents for use in scientific, laboratory and research purposes; biochemical test kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding, for scientific, laboratory and research purposes; assay kits comprised of assays and for non-medical purposes for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding

Assays and reagents for use in medical, diagnostic and therapeutic purposes; biochemical test kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding, for medical, diagnostic and therapeutic purposes; assay kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation, and antibody binding, for medical, diagnostic and therapeutic purposes; assay kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation, and antibody binding, for use in identifying candidate patient populations for specific therapeutic treatments

Providing scientific research information and analysis relating to biochemicals, proteolytic activation, antibody binding, therapeutic treatments, patient recovery, and the identification of candidate patients for specific therapeutic treatments; testing, research, design and development services in the field of biochemicals for scientific purposes; research, design and development of assays for measuring, monitoring, testing and analyzing proteolytic activation, antibody binding, therapeutic treatments and patient recovery, and for identifying candidate patient populations for specific therapeutic treatments
ihz

General Information


Serial Number86739853
Word MarkIHZ
Filing DateThursday, August 27, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 24, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 29, 2016

Trademark Statements


Goods and ServicesAssays and reagents for use in scientific, laboratory and research purposes; biochemical test kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding, for scientific, laboratory and research purposes; assay kits comprised of assays and for non-medical purposes for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding
Goods and ServicesAssays and reagents for use in medical, diagnostic and therapeutic purposes; biochemical test kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding, for medical, diagnostic and therapeutic purposes; assay kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation, and antibody binding, for medical, diagnostic and therapeutic purposes; assay kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation, and antibody binding, for use in identifying candidate patient populations for specific therapeutic treatments
Goods and ServicesProviding scientific research information and analysis relating to biochemicals, proteolytic activation, antibody binding, therapeutic treatments, patient recovery, and the identification of candidate patients for specific therapeutic treatments; testing, research, design and development services in the field of biochemicals for scientific purposes; research, design and development of assays for measuring, monitoring, testing and analyzing proteolytic activation, antibody binding, therapeutic treatments and patient recovery, and for identifying candidate patient populations for specific therapeutic treatments

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, September 1, 2015
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 1, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 1, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCytomX Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameCytomX Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Monday, June 24, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 24, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 24, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 23, 2018EXTENSION 5 GRANTED
Tuesday, October 16, 2018EXTENSION 5 FILED
Tuesday, October 23, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 16, 2018TEAS EXTENSION RECEIVED
Friday, April 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 18, 2018EXTENSION 4 GRANTED
Wednesday, April 18, 2018EXTENSION 4 FILED
Wednesday, April 18, 2018TEAS EXTENSION RECEIVED
Saturday, October 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 19, 2017EXTENSION 3 GRANTED
Thursday, October 19, 2017EXTENSION 3 FILED
Thursday, October 19, 2017TEAS EXTENSION RECEIVED
Saturday, April 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 13, 2017EXTENSION 2 GRANTED
Thursday, April 13, 2017EXTENSION 2 FILED
Thursday, April 13, 2017TEAS EXTENSION RECEIVED
Tuesday, October 18, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 14, 2016EXTENSION 1 GRANTED
Friday, October 14, 2016EXTENSION 1 FILED
Friday, October 14, 2016TEAS EXTENSION RECEIVED
Tuesday, May 24, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 29, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 29, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 9, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 23, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 16, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 11, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 11, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 10, 2016ASSIGNED TO LIE
Thursday, February 4, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 18, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 18, 2015NON-FINAL ACTION E-MAILED
Wednesday, November 18, 2015NON-FINAL ACTION WRITTEN
Thursday, November 12, 2015ASSIGNED TO EXAMINER
Tuesday, September 1, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 31, 2015NEW APPLICATION ENTERED IN TRAM